Omega 3 fatty acid: Clinical Trials

29 trials of Omega 3 fatty acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 11 unknown, 2 terminated, 1 withdrawn. 9 Not applicable, 7 Phase 2, 7 Phase 3, 5 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 6, Unknown 2, Terminated 1
Phase 27Completed 3, Unknown 2, Terminated 1, Withdrawn 1
Phase 37Completed 6, Unknown 1
Phase 45Unknown 4, Completed 1
Phase 12Completed 1, Unknown 1

Follow Omega 3 fatty acid: new trials by email Literature Review of Omega 3 fatty acid trials Research Report on Omega 3 fatty acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial
Omega 3 fatty acid, Placebo of Omega-3 fatty acid softgel capsule - Autism Spectrum Disorder
Phase 2CompletedBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh642023-09-192025-07-09
Multi-factor Model Constraction for Early Warning and Diagnosis of MDD
Omega 3 fatty acid - Major Depressive Disorder, Bipolar Disorder
Phase 4UnknownShanghai Mental Health Center6002022-08-232022-09-07
Fish Oil (Omega 3 ) in Sjogren's Syndrome
Omega 3 fatty acid, Placebo - Sjogren's Syndrome
Phase 2 / Phase 3CompletedHawler Medical University1002021-09-022024-02-28
Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient
Omega 3 fatty acid, VitaE - Mastalgia
Phase 4UnknownCairo University1202021-01-012021-01-05
Omega-3 Oil Use in COVID-19 Patients in Qatar
Omega 3 fatty acid - COVID-19
Phase 3UnknownHamad Medical Corporation3722020-12-242021-04-08
Effects of Omega-3 Fatty Acids on Muscle Wasting
omega 3 fatty acid - Muscle Wasting
UnknownKaradeniz Technical University802020-07-202020-10-14
Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
Simvastatin 40mg, Fenofibrate 200mg, Omega 3 fatty acid - Diabetic Retinopathy
Phase 4UnknownAlaa Hassan ElBaz802020-02-012020-01-18
Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Omega 3 fatty acid, Placebos - Dry Eye
Phase 3CompletedOmegaD LLC3222019-11-182024-07-29
Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers
Omega 3 fatty acid - Lung Cancer
Phase 2UnknownBritish Columbia Cancer Agency422019-06-012019-05-07
Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation
Omega 3 fatty acid - Liver Transplantation
Phase 2UnknownInstitute of Liver and Biliary Sciences, India1242018-12-022019-07-23
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
Cholecalciferol, Omega 3 fatty acid - Diabetes Mellitus, Type 1, Hypoglycemia
Phase 1 / Phase 2CompletedRodolfo Alejandro272018-07-232025-09-17
Omega 3 and Fibre Intervention Study to Improve Metabolic Health
Omega 3 fatty acid, Inulin fibre - Metabolic Disease, Immune Function
Not applicableUnknownGuy's and St Thomas' NHS Foundation Trust802018-05-312018-08-02
Omega-3 PUFA for Treatment of Patients With Idiopathic Oligoasthenoteratospermia
Omega 3 fatty acid, Placebo oral capsule - Male Infertility Due to Hypospermatogenesis
Phase 1UnknownJinling Hospital, China302017-11-082021-09-16
The Omega-3 Fatty Acid Paediatric Depression Trial
Omega 3 fatty acid, Placebo oil - Depression
Phase 3CompletedGregor Berger2572017-04-282023-04-06
Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury
Omega 3 fatty acid, Safflower seed oil - TBI
Phase 2WithdrawnUniversity of Pennsylvania2017-01-012022-10-13
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Omega-3 Fatty Acid, Placebo - Arthralgia, Breast Neoplasms
Not applicableCompletedOhio State University Comprehensive Cancer Center752016-10-122023-02-27
Effect of Omega 3 as an Immunomodulator Adjunct to Periodontal Debridement
Lactose tab, Omega 3 - Periodontitis
Not applicableCompletedUniversidad Nacional Andres Bello182016-03-012020-05-21
TEFA Family Prevention: Glutenfree Diet to Preserve Beta-cell Function
Gluten free diet, Omega 3 fatty acid, Vitamin D - Prediabetes, Type 1 Diabetes
Not applicableUnknownLund University602015-12-012021-10-26
Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India.
Docosa-hexaenoic acid (DHA), Placebo - Pregnancy
Phase 3CompletedCentre for Chronic Disease Control, India6002015-12-012017-02-23
Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2)
Docosa Hexaenoic Acid (DHA), Placebo - Pregnancy
Phase 3CompletedPublic Health Foundation of India9572015-12-012021-03-18

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 1 (2)  ·  Dry Eye Syndromes (2)  ·  Arthralgia (1)  ·  Autism Spectrum Disorder (1)  ·  Bipolar Disorder (1)  ·  Brain Injuries, Traumatic (1)  ·  Breast Feeding (1)  ·  Breast Neoplasms (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Periodontitis (1)  ·  Critical Illness (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)

Sponsors

Alaa Hassan ElBaz (1)  ·  Amen Clinics, Inc. (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  British Columbia Cancer Agency (1)  ·  Cairo University (1)  ·  Centre for Chronic Disease Control, India (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Federal University of São Paulo (1)  ·  Gregor Berger (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Hamad Medical Corporation (1)  ·  Hawler Medical University (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Jinling Hospital, China (1)  ·  Karadeniz Technical University (1)

Countries

United States (8)  ·  India (4)  ·  China (2)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Chile (1)  ·  Egypt (1)  ·  Iraq (1)  ·  Mexico (1)  ·  Qatar (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Ahmet Oguzhan Kucuk, MD (1)  ·  Ana Valdez, Dr (1)  ·  Aryan MF Jalal, M.B.CH.B (1)  ·  Camillo Ricordi, M.D. (1)  ·  Daniel G Amen, MD (1)  ·  Girish D Deore, BDS (1)  ·  Ibtihal HH Faraj, M-B.CH.B (1)  ·  Jun Chen, M.D.,Ph.D (1)  ·  Klaus Schmeck, MD (1)  ·  Maricela Rodriguez-Cruz, PhD (1)  ·  Mariely A Navarrete Riffo, MSc (1)  ·  Mariely A Navarrete, MSc (1)

Results publications

PMID 15643744, PMID 20307284, PMID 21304145, PMID 21615001, PMID 24052491, PMID 24616831, PMID 25389003, PMID 25406739, PMID 25441679, PMID 26296857, PMID 28987470, PMID 29938621, PMID 30077178, PMID 30420291, PMID 31827448, PMID 31900292, PMID 33023067, PMID 33668849, PMID 33855205, PMID 34301320, PMID 34779542, PMID 34983671, PMID 35005781, PMID 36532545, PMID 37126739, PMID 37425294, PMID 40061518, PMID 40894517, PMID 41481294

NIH funding

2016 (1)